Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.
Biochemistry. 2012 Jul 24;51(29):5791-803. doi: 10.1021/bi300391m. Epub 2012 Jul 9.
The enzyme N(1)-(5'-phosphoribosyl) adenosine-5'-monophosphate cyclohydrolase (PR-AMP cyclohydrolase) is a Zn(2+) metalloprotein encoded by the hisI gene. It catalyzes the third step of histidine biosynthesis, an uncommon ring-opening of a purine heterocycle for use in primary metabolism. A three-dimensional structure of the enzyme from Methanobacterium thermoautotrophicum has revealed that three conserved cysteine residues occur at the dimer interface and likely form the catalytic site. To investigate the functions of these cysteines in the enzyme from Methanococcus vannielii, a series of biochemical studies were pursued to test the basic hypothesis regarding their roles in catalysis. Inactivation of the enzyme activity by methyl methane thiosulfonate (MMTS) or 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) also compromised the Zn(2+) binding properties of the protein inducing loss of up to 90% of the metal. Overall reaction stoichiometry and the potassium cyanide (KCN) induced cleavage of the protein suggested that all three cysteines were modified in the process. The enzyme was protected from DTNB-induced inactivation by inclusion of the substrate N(1)-(5'-phosphoribosyl)adenosine 5'-monophosphate; (PR-AMP), while Mg(2+), a metal required for catalytic activity, enhanced the rate of inactivation. Site-directed mutations of the conserved C93, C109, C116 and the double mutant C109/C116 were prepared and analyzed for catalytic activity, Zn(2+) content, and reactivity with DTNB. Substitution of alanine for each of the conserved cysteines showed no measurable catalytic activity, and only the C116A was still capable of binding Zn(2+). Reactions of DTNB with the C109A/C116A double mutant showed that C93 is completely modified within 0.5 s. A model consistent with these data involves a DTNB-induced mixed disulfide linkage between C93 and C109 or C116, followed by ejection of the active site Zn(2+) and provides further evidence that the Zn(2+) coordination site involves the three conserved cysteine residues. The C93 reactivity is modulated by the presence of the Zn(2+) and Mg(2+) and substantiates the role of this residue as a metal ligand. In addition, Mg(2+) ligand binding site(s) indicated by the structural analysis were probed by site-directed mutagenesis of three key aspartate residues flanking the conserved C93 which were shown to have a functional impact on catalysis, cysteine activation, and metal (zinc) binding capacity. The unique amino acid sequence, the dynamic properties of the cysteine ligands involved in Zn(2+) coordination, and the requirement for a second metal (Mg(2+)) are discussed in the context of their roles in catalysis. The results are consistent with a Zn(2+)-mediated activation of H(2)O mechanism involving histidine as a general base that has features similar to but distinct from those of previously characterized purine and pyrimidine deaminases.
酶 N(1)-(5'-磷酸核糖基)腺嘌呤-5'-单磷酸环化水解酶 (PR-AMP 环化水解酶) 是由 hisI 基因编码的一种 Zn(2+) 金属蛋白。它催化组氨酸生物合成的第三步,即嘌呤杂环的罕见开环,用于初级代谢。来自产甲烷菌 Thermoautotrophicum 的酶的三维结构表明,三个保守的半胱氨酸残基存在于二聚体界面上,可能形成催化位点。为了研究这些半胱氨酸在 Methanococcus vannielii 中的酶中的功能,进行了一系列生化研究,以检验关于它们在催化中的作用的基本假设。甲硫氨酸甲基硫代磺酸 (MMTS) 或 5,5'-二硫代双(2-硝基苯甲酸) (DTNB) 的酶活性失活也会破坏蛋白质的 Zn(2+) 结合特性,导致高达 90%的金属丢失。总体反应化学计量和氰化钾 (KCN) 诱导的蛋白质裂解表明,所有三个半胱氨酸都在该过程中发生了修饰。包含底物 N(1)-(5'-磷酸核糖基)腺苷 5'-单磷酸 (PR-AMP) 的情况下,酶可免受 DTNB 诱导的失活;而 Mg(2+),一种催化活性所需的金属,可提高失活的速度。制备并分析了保守的 C93、C109、C116 和双突变体 C109/C116 的定点突变体的催化活性、Zn(2+) 含量和与 DTNB 的反应性。每个保守半胱氨酸的丙氨酸取代均未显示出可测量的催化活性,只有 C116A 仍能够结合 Zn(2+)。DTNB 与 C109A/C116A 双突变体的反应表明,C93 在 0.5 秒内完全被修饰。与这些数据一致的模型涉及 DTNB 诱导的 C93 和 C109 或 C116 之间的混合二硫键连接,随后是活性位点 Zn(2+) 的排出,并进一步证明 Zn(2+) 配位位点涉及三个保守的半胱氨酸残基。C93 的反应性受 Zn(2+)和 Mg(2+) 的存在调节,并证实了该残基作为金属配体的作用。此外,结构分析表明的 Mg(2+) 配体结合位点通过定点突变三个关键的天冬氨酸残基进行了探测,这些残基对催化、半胱氨酸激活和金属 (锌) 结合能力有功能影响。独特的氨基酸序列、涉及 Zn(2+) 配位的半胱氨酸配体的动态特性以及对第二种金属 (Mg(2+)) 的需求,在其催化作用的背景下进行了讨论。结果与涉及组氨酸作为通用碱的 Zn(2+)-介导的 H(2)O 激活机制一致,其特征与先前表征的嘌呤和嘧啶脱氨酶相似但又不同。